Overview
Mark Greene is an Oncologist in Rockville, Maryland. Dr. Greene is rated as an Advanced provider by MediFind in Salpingo-Oophorectomy. His top areas of expertise are Testicular Cancer, Ovarian Cancer, Breast Cancer, Breast Cancer in Men, and Salpingo-Oophorectomy.
His clinical research consists of co-authoring 232 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Salpingo-Oophorectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Medstar Medical Group Ii LLC
Claudine Isaacs is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Isaacs is rated as a Distinguished provider by MediFind in Salpingo-Oophorectomy. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy.
Medstar Medical Group Ii LLC
Candace Mainor is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Mainor is rated as an Advanced provider by MediFind in Salpingo-Oophorectomy. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy. Dr. Mainor is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as a Distinguished provider by MediFind in Salpingo-Oophorectomy. Her top areas of expertise are Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ovarian CancerDr. Greene isDistinguished. Learn about Ovarian Cancer.
- Testicular CancerDr. Greene isDistinguished. Learn about Testicular Cancer.
- Advanced
- Breast CancerDr. Greene isAdvanced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Greene isAdvanced. Learn about Breast Cancer in Men.
- Salpingo-OophorectomyDr. Greene isAdvanced. Learn about Salpingo-Oophorectomy.
- Experienced
- Anal CancerDr. Greene isExperienced. Learn about Anal Cancer.
- BRCA Positive Breast CancerDr. Greene isExperienced. Learn about BRCA Positive Breast Cancer.
- Familial Prostate CancerDr. Greene isExperienced. Learn about Familial Prostate Cancer.
- Hairy Cell Leukemia (HCL)Dr. Greene isExperienced. Learn about Hairy Cell Leukemia (HCL).
- MenopauseDr. Greene isExperienced. Learn about Menopause.
- Prostate CancerDr. Greene isExperienced. Learn about Prostate Cancer.

